ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 159631 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 159631; 2) Community: the network communities that were significantly associated with the response to NSC 159631; 3) Molecule: the relationships between components within communities and NSC 159631; 4) MDR: the compounds that were significantly associated with the NSC 159631.

NSC Compound Enrichment Correlation
NSC 648365 Insulin-Methotrexate conjugate 0.0462077035966084 0.29781169
NSC 650012 Null 0.0462077035966084 0.29021694
NSC 650262 Null 0.0462077035966084 0.052947387
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0462077035966084 0.36517494
NSC 662253 Null 0.0462077035966084 0.067761182
NSC 662302 Null 0.0462077035966084 0.40397099
NSC 668833 Null 0.0462077035966084 -0.08691265
NSC 671404 Null 0.0462077035966084 0.26453754
NSC 671660 Null 0.0462077035966084 0.35639569
NSC 673188 - 0.0462077035966084 0.45638533
Total:136  Current:127    [First] [Prev] [Next] [Last]